{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:27:54Z","timestamp":1793647674781,"version":"4.5.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s15010-026-02905-9","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:35:07Z","timestamp":1785425707000},"page":"2691-2699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of SGLT2 inhibitors on asymptomatic bacteriuria in T2DM: prevalence, pathogens and risk factors"],"prefix":"10.1007","volume":"54","author":[{"given":"Rahul","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-9142","authenticated-orcid":false,"given":"Hamid","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"7","key":"2905_CR1","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00125-024-06102-x","volume":"67","author":"RIG Holt","year":"2024","unstructured":"Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67(7):1168\u201380. https:\/\/doi.org\/10.1007\/s00125-024-06102-x.","journal-title":"Diabetologia"},{"issue":"5","key":"2905_CR2","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.4103\/jfmpc.jfmpc_1894_20","volume":"10","author":"A Tauseef","year":"2021","unstructured":"Tauseef A, Zafar M, Syyed E, Thirumalareddy J, Sood A, Mirza M. Asymptomatic Bacteriuria (ASB) in diabetic patients: Treat or not to treat: A prospective, observational study conducted at a tertiary care hospital. J Family Med Prim Care. 2021;10(5):1963\u20139. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1894_20.","journal-title":"J Family Med Prim Care"},{"issue":"Suppl1","key":"2905_CR3","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.4103\/2230-8210.94253","volume":"16","author":"J Casqueiro","year":"2012","unstructured":"Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl1):S27\u201336. https:\/\/doi.org\/10.4103\/2230-8210.94253.","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"2905_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archinte.161.11.1421","volume":"161","author":"SE Geerlings","year":"2001","unstructured":"Geerlings SE, Stolk RP, Camps MJ, et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med. 2001;161(11):1421\u20137. https:\/\/doi.org\/10.1001\/archinte.161.11.1421.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2905_CR5","doi-asserted-by":"publisher","first-page":"115495","DOI":"10.4239\/wjd.v17.i2.115495","volume":"17","author":"ABM Kamrul-Hasan","year":"2026","unstructured":"Kamrul-Hasan ABM, Shaikh S, Ashraf H, et al. Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes fasting during Ramadan: A meta-analysis. World J Diabetes. 2026;17(2):115495. https:\/\/doi.org\/10.4239\/wjd.v17.i2.115495.","journal-title":"World J Diabetes"},{"issue":"1","key":"2905_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.dsx.2018.09.001","volume":"13","author":"H Ashraf","year":"2019","unstructured":"Ashraf H, Ahmad J. Cardiovascular outcome trials in type 2 diabetes: A critical analysis. Diabetes Metab Syndr. 2019;13(1):300\u20135. https:\/\/doi.org\/10.1016\/j.dsx.2018.09.001.","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"2905_CR7","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/medicina60121974","volume":"60","author":"L Iordan","year":"2024","unstructured":"Iordan L, Avram VF, Timar B, et al. Safety of SGLT2 Inhibitors and Urinary Tract Infections in Clinical Practice-A Cross-Sectional Study. Med (Kaunas). 2024;60(12):1974. https:\/\/doi.org\/10.3390\/medicina60121974. Published 2024 Dec 1.","journal-title":"Med (Kaunas)"},{"key":"2905_CR8","doi-asserted-by":"publisher","first-page":"1632790","DOI":"10.3389\/frabi.2026.1632790","volume":"5","author":"A Shinde","year":"2026","unstructured":"Shinde A, Mohan A, Bulusu VM, et al. Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine. Front Antibiot. 2026;5:1632790. https:\/\/doi.org\/10.3389\/frabi.2026.1632790. Published 2026 Jan 28.","journal-title":"Front Antibiot"},{"issue":"1","key":"2905_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/bco2.286","volume":"5","author":"D Thompson","year":"2023","unstructured":"Thompson D, Xu J, Ischia J, Bolton D. Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. BJUI Compass. 2023;5(1):5\u201311. https:\/\/doi.org\/10.1002\/bco2.286. Published 2023 Aug 31.","journal-title":"BJUI Compass"},{"key":"2905_CR10","doi-asserted-by":"publisher","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. J Clin Microbiol. 2021;59(12):e0021321. https:\/\/doi.org\/10.1128\/JCM.00213-21","DOI":"10.1128\/JCM.00213-21"},{"issue":"2","key":"2905_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12020-023-03469-6","volume":"82","author":"M Dai","year":"2023","unstructured":"Dai M, Hua S, Yang J, et al. Incidence and risk factors of asymptomatic bacteriuria in patients with type 2 diabetes mellitus: a meta-analysis. Endocrine. 2023;82(2):263\u201381. https:\/\/doi.org\/10.1007\/s12020-023-03469-6.","journal-title":"Endocrine"},{"issue":"1","key":"2905_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dsx.2020.12.043","volume":"15","author":"BA Laway","year":"2021","unstructured":"Laway BA, Nabi T, Bhat MH, Fomda BA. Prevalence, clinical profile and follow up of asymptomatic bacteriuria in patients with type 2 diabetes-prospective case control study in Srinagar, India. Diabetes Metab Syndr. 2021;15(1):455\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2020.12.043.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"2905_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4103\/jfmpc.jfmpc_403_18","volume":"8","author":"A Bharti","year":"2019","unstructured":"Bharti A, Chawla SPS, Kumar S, et al. Asymptomatic bacteriuria among the patients of type 2 diabetes mellitus. J Family Med Prim Care. 2019;8(2):539\u201343. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_403_18.","journal-title":"J Family Med Prim Care"},{"key":"2905_CR14","first-page":"100226","volume":"15","author":"RE Carpenter","year":"2025","unstructured":"Carpenter RE. Metabolic and microbial crossroads: Sodium-glucose cotransporter-2 inhibitors and urinary tract infections in (Asian) diabetes care. Health Sci Rev. 2025;15:100226.","journal-title":"Health Sci Rev"},{"issue":"4","key":"2905_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s13577-023-00905-7","volume":"36","author":"PY Thimmappa","year":"2023","unstructured":"Thimmappa PY, Vasishta S, Ganesh K, Nair AS, Joshi MB. Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections. Hum Cell. 2023;36(4):1265\u201382. https:\/\/doi.org\/10.1007\/s13577-023-00905-7.","journal-title":"Hum Cell"},{"issue":"2","key":"2905_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15605\/jafes.037.02.04","volume":"37","author":"P Ferwani","year":"2022","unstructured":"Ferwani P, Maldar A, Shah N, Chauhan P, Chadha M. Prevalence of Bacterial Urinary Tract Infection Among Patients With Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter-2 Inhibitors: A Prospective Real-World Setting Study. J ASEAN Fed Endocr Soc. 2022;37(2):5\u20138. https:\/\/doi.org\/10.15605\/jafes.037.02.04.","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"12","key":"2905_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/medicines9120059","volume":"9","author":"S Uitrakul","year":"2022","unstructured":"Uitrakul S, Aksonnam K, Srivichai P, Wicheannarat S, Incomenoy S. The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Med (Basel). 2022;9(12):59. https:\/\/doi.org\/10.3390\/medicines9120059. Published 2022 Nov 22.","journal-title":"Med (Basel)"},{"issue":"3","key":"2905_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s11255-023-03798-5","volume":"56","author":"E Akku\u015f","year":"2024","unstructured":"Akku\u015f E, G\u00f6k\u00e7ay Canpolat A, Demir \u00d6, \u00c7orap\u00e7\u0131o\u011flu D, \u015eahin M. Asymptomatic pyuria and bacteriuria are not risk factors for urinary tract infection in women with type 2 diabetes mellitus initiated SGLT2 inhibitors. Int Urol Nephrol. 2024;56(3):1165\u201372. https:\/\/doi.org\/10.1007\/s11255-023-03798-5.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"2905_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17(5):319\u201334. https:\/\/doi.org\/10.1038\/s41581-021-00393-8.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"2905_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4239\/wjd.v13.i10.809","volume":"13","author":"J Talapko","year":"2022","unstructured":"Talapko J, Me\u0161trovi\u0107 T, \u0160krlec I. Growing importance of urogenital candidiasis in individuals with diabetes: A narrative review. World J Diabetes. 2022;13(10):809\u201321. https:\/\/doi.org\/10.4239\/wjd.v13.i10.809.","journal-title":"World J Diabetes"},{"key":"2905_CR21","doi-asserted-by":"publisher","first-page":"108210","DOI":"10.1016\/j.maturitas.2025.108210","volume":"194","author":"R Scairati","year":"2025","unstructured":"Scairati R, Auriemma RS, Del Vecchio G, et al. Diabetes mellitus, vaginal microbiome and sexual function: Outcomes in postmenopausal women. Maturitas. 2025;194:108210. https:\/\/doi.org\/10.1016\/j.maturitas.2025.108210.","journal-title":"Maturitas"},{"issue":"3","key":"2905_CR22","doi-asserted-by":"publisher","first-page":"e0344986","DOI":"10.1371\/journal.pone.0344986","volume":"21","author":"J Kaaya","year":"2026","unstructured":"Kaaya J, Manguzu MA, Buma D, et al. Urinary tract infections, risk factors and antimicrobial resistance patterns in heart failure patients on sodium-glucose transporter 2 inhibitors: Evidence from Jakaya Kikwete Cardiac Institute in Tanzania. PLoS ONE. 2026;21(3):e0344986. https:\/\/doi.org\/10.1371\/journal.pone.0344986. Published 2026 Mar 26.","journal-title":"PLoS ONE"},{"key":"2905_CR23","volume-title":"Annual Surveillance of Antimicrobial Resistance in India 2022\u20132024","author":"Indian Council of Medical Research","year":"2024","unstructured":"Indian Council of Medical Research. Annual Surveillance of Antimicrobial Resistance in India 2022\u20132024. New Delhi: ICMR; 2024."},{"issue":"21","key":"2905_CR24","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.3390\/jcm13216509","volume":"13","author":"JJ Gorgojo-Mart\u00ednez","year":"2024","unstructured":"Gorgojo-Mart\u00ednez JJ, G\u00f3rriz JL, Cebri\u00e1n-Cuenca A, Castro Conde A, Velasco Arribas M. Clinical recommendations for managing genitourinary adverse effects in patients treated with SGLT-2 inhibitors: a multidisciplinary expert consensus. J Clin Med 2024;13(21):6509 https:\/\/doi.org\/10.3390\/jcm13216509","journal-title":"J Clin Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02905-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:49:39Z","timestamp":1793645379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02905-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2905"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02905-9","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}